Diabetes under control: Diabetes and depression

American Journal of Nursing

Volumn 104, Issue 9, 2004, Pages 56-59

  Harper Jaques, Sandy ^a  

^a Dominican Sisters Family Health Service Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; GLUCOSE;

ATYPICAL DEPRESSION; BEHAVIOR MODIFICATION; CHRONIC DISEASE; CLINICAL FEATURE; COGNITIVE THERAPY; CORONARY RISK; DIABETES CONTROL; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; GLUCOSE BLOOD LEVEL; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INSULIN DEPENDENT DIABETES MELLITUS; ISCHEMIC HEART DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NURSE ATTITUDE; NURSE PATIENT RELATIONSHIP; REVIEW; SEXUAL DYSFUNCTION; ADULT; ARTICLE; CASE REPORT; DEPRESSION; FEMALE; NURSING; PSYCHOLOGICAL ASPECT; PSYCHOTHERAPY;

ADULT; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; NURSE-PATIENT RELATIONS; PSYCHOTHERAPY;

EID: 8744289585     PISSN: 0002936X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000446-200409000-00025     Document Type: Review

References (21)

1. Anderson RJ, et al. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 2001;24(6):1069-78.
2. Harper-Jacques S. Addressing the needs of the person with diabetes and depression. Canadian Journal of Diabetes Care 2000;24(Suppl 2):51-7.
3. Barden N. Implication of the hypothalamic-pituitary-adrenal axis in the physiopathology of depression. J Psychiatry Neurosci 2004;29(3):185-93.
4. Kovacs M, et al. Major depressive disorder in youths with IDDM. A controlled prospective study of course and outcome. Diabetes Care 1997;20(1):45-51.
5. Lustman PJ, Clouse RE. Treatment of depression in diabetes: impact on mood and medical outcome. J Psychosom Res 2002;53(4):917-24.
6. Kinder LS, et al. Depressive symptomatology and coronary heart disease in type I diabetes mellitus: a study of possible mechanisms. Health Psychol 2002;21(6):542-52.
7. de Groot M, et al. Association of depression and diabetes complications: a meta-analysis. Psychosom Med 2001;63(4):619-30.
8. Lustman PJ, et al. Predicting response to cognitive behavior therapy of depression in type 2 diabetes. Gen Hosp Psychiatry 1998;20(5):302-6.
9. Genuth SM. The case for blood glucose control. Adv Intern Med 1995;40:573-623.
10. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-IV. 4th ed. Washington, DC: The Association; 1994.
11. Sharp LK, Lipsky MS. Screening for depression across the lifespan: a review of measures for use in primary care settings. Am Fam Physician 2002;66(6):1001-8.
12. Egede L, Zheng D. Independent factors associated with major depressive disorder in a national sample of individuals with diabetes. Diabetes Care 2003;26(1):104-11.
13. Bailey BJ. Mediators of depression in adults with diabetes. Clin Nurs Res 1996;5(1):28-42.
14. Lustman PJ, et al. Cognitive behavior therapy for depression in type 2 diabetes mellitus. A randomized, controlled trial. Ann Intern Med 1998;129(8):613-21.
15. Delamater A, et al. Psychosocial therapies in diabetes. Diabetes Care 2001;24(7):1286-92.
16. Glick Miller S. Family therapy for recurrent diabetic ketoacidosis. Fam Syst Health 1996;14:303-14.
17. Mourilhe P, Stokes PE. Risks and benefits of selective serotonin reuptake inhibitors in the treatment of depression. Drug Saf 1998;18(1):57-82.
18. Goodnick PJ. Use of antidepressants in treatment of comorbid diabetes mellitus and depression as well as in diabetic neuropathy. Ann Clin Psychiatry 2001;13(1):31-41.
19. Goodnick PJ, et al. Sertraline in coexisting major depression and diabetes mellitus. Psychopharmacol Bull 1997;33(2):261-4.
20. Lustman PJ, et al. Fluoxetine for depression in diabetes: a randomized double-blind placebo-controlled trial. Diabetes Care 2000;23(5):618-23.
21. Robinson C. Health care relationships revisited. Journal of Family Nursing 1996;2(2):152-73.